The lysosomal storage disease continuum with ageing-related neurodegenerative disease

Ageing Research Reviews

Volumn 32, Issue , 2016, Pages 104-121

  Lloyd Evans, Emyr ^a   Haslett, Luke J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Ageing; Alzheimer's disease; Lysosomal storage diseases; Lysosome; Parkinson's disease

Indexed keywords

CALCIUM ION; ENZYME; MEMBRANE PROTEIN; PRESENILIN;

AGING; ALZHEIMER DISEASE; AUTOPHAGY; CELL FUNCTION; CELL VACUOLE; CLEARANCE; DEGENERATIVE DISEASE; ENDOCYTOSIS; FAMILIAL DISEASE; GAUCHER DISEASE; HOMEOSTASIS; HUMAN; KUFOR RAKEB SYNDROME; LOSS OF FUNCTION MUTATION; LYSOSOME; LYSOSOME STORAGE DISEASE; MOLECULE; MUCOLIPIDOSIS TYPE 4; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PH; PHENOTYPE; PREVALENCE; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; ULTRASTRUCTURE; METABOLISM; PHYSIOLOGY;

AGING; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; NEURODEGENERATIVE DISEASES;

EID: 84996553998     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.07.005     Document Type: Review

References (247)

1. Aarsland, D., Zaccai, J., Brayne, C., A systematic review of prevalence studies of dementia in Parkinson's disease. Mov. Disord. 20 (2005), 1255–1263.
2. Aberg, L., Liewendahl, K., Nikkinen, P., Autti, T., Rinne, J.O., Santavuori, P., Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms. Neurology 54 (2000), 1069–1074.
3. Alroy, J., Ucci, A.A., Skin biopsy: a useful tool in the diagnosis of lysosomal storage diseases. Ultrastruct. Pathol. 30 (2006), 489–503.
4. Altarescu, G., Sun, M., Moore, D.F., Smith, J.A., Wiggs, E.A., Solomon, B.I., Patronas, N.J., Frei, K.P., Gupta, S., Kaneski, C.R., Quarrell, O.W., Slaugenhaupt, S.A., Goldin, E., Schiffmann, R., The neurogenetics of mucolipidosis type IV. Neurology 59 (2002), 306–313.
5. Armstrong, A., Mattsson, N., Appelqvist, H., Janefjord, C., Sandin, L., Agholme, L., Olsson, B., Svensson, S., Blennow, K., Zetterberg, H., Kagedal, K., Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease. Neuromol. Med. 16 (2014), 150–160.
6. Auer, I.A., Schmidt, M.L., Lee, V.M., Curry, B., Suzuki, K., Shin, R.W., Pentchev, P.G., Carstea, E.D., Trojanowski, J.Q., Paired helical filament tau (PHFtau) in Niemann-pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol. 90 (1995), 547–551.
7. Bach, G., Chen, C.S., Pagano, R.E., Elevated lysosomal pH in Mucolipidosis type IV cells. Clin. Chim. Acta 280 (1999), 173–179.
8. Bach, G., Zeevi, D.A., Frumkin, A., Kogot-Levin, A., Mucolipidosis type IV and the mucolipins. Biochem. Soc. Trans. 38 (2010), 1432–1435.
9. Bach, G., Mucolipin 1: endocytosis and cation channel—a review. Pflugers Arch. 451 (2005), 313–317.
10. Bae, M., Patel, N., Xu, H., Lee, M., Tominaga-Yamanaka, K., Nath, A., Geiger, J., Gorospe, M., Mattson, M.P., Haughey, N.J., Activation of TRPML1 clears intraneuronal Abeta in preclinical models of HIV infection. J. Neurosci. 34 (2014), 11485–11503.
11. Bandaru, V.V., Troncoso, J., Wheeler, D., Pletnikova, O., Wang, J., Conant, K., Haughey, N.J., ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain. Neurobiol. Aging 30 (2009), 591–599.
12. Bargal, R., Bach, G., Phosphatidylcholine storage in mucolipidosis IV. Clin. Chim. Acta 181 (1989), 167–174.
13. Baris, H.N., Cohen, I.J., Mistry, P.K., Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history. Pediatr. Endocrinol. Rev. 12:Suppl. 1 (2014), 72–81.
14. Baumkotter, J., Cantz, M., Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients. Inhibition of the activity in vitro by sulfated glycosaminoglycans and other compounds. Biochim. Biophys. Acta 761 (1983), 163–170.
15. Bendikov-Bar, I., Rapaport, D., Larisch, S., Horowitz, M., Parkin-mediated ubiquitination of mutant glucocerebrosidase leads to competition with its substrates PARIS and ARTS. Orphanet J. Rare Dis., 9, 2014, 86.
16. Berridge, M.J., Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 7 (2013), 2–13.
17. Bezprozvanny, I., Mattson, M.P., Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31 (2008), 454–463.
18. Bezprozvanny, I., Presenilins and calcium signaling-systems biology to the rescue. Sci. Signal., 6, 2013, pe24.
19. Bhambhani, V., Introne, W.J., Lungu, C., Cullinane, A., Toro, C., Chediak-Higashi syndrome presenting as young-onset levodopa-responsive parkinsonism. Mov. Disord. 28 (2013), 127–129.
20. Bi, X., Zhou, J., Lynch, G., Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease. Exp. Neurol. 158 (1999), 312–327.
21. Bird, T.D., Genotypes, phenotypes, and frontotemporal dementia: take your pick. Neurology 50 (1998), 1526–1527.
22. Boland, B., Smith, D.A., Mooney, D., Jung, S.S., Walsh, D.M., Platt, F.M., Macroautophagy is not directly involved in the metabolism of amyloid precursor protein. J. Biol. Chem. 285 (2010), 37415–37426.
23. Borbon, I.A., Erickson, R.P., Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's. J. Appl. Genet. 52 (2011), 213–218.
24. Bourdenx, M., Daniel, J., Genin, E., Soria, F.N., Blanchard-Desce, M., Bezard, E., Dehay, B., Nanoparticles restore lysosomal acidification defects: implication for Parkinson and other lysosomal-related diseases. Autophagy, 2016, 0.
25. Bowler, R.M., Roels, H.A., Nakagawa, S., Drezgic, M., Diamond, E., Park, R., Koller, W., Bowler, R.P., Mergler, D., Bouchard, M., Smith, D., Gwiazda, R., Doty, R.L., Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup. Environ. Med. 64 (2007), 167–177.
26. Braak, H., Del Tredici, K., Neuroanatomy and pathology of sporadic Parkinson's disease. Adv. Anat. Embryol. Cell Biol. 201 (2009), 1–119.
27. Caciotti, A., Catarzi, S., Tonin, R., Lugli, L., Perez, C.R., Michelakakis, H., Mavridou, I., Donati, M.A., Guerrini, R., d'Azzo, A., Morrone, A., Galactosialidosis: review and analysis of CTSA gene mutations. Orphanet J. Rare Dis., 8, 2013, 114.
28. Campos, D., Monaga, M., Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms. Metab. Brain Dis. 27 (2012), 121–129.
29. Carstea, E.D., Morris, J.A., Coleman, K.G., Loftus, S.K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M.A., Pavan, W.J., Krizman, D.B., Nagle, J., Polymeropoulos, M.H., Sturley, S.L., Ioannou, Y.A., Higgins, M.E., Comly, M., Cooney, A., Brown, A., Kaneski, C.R., Blanchette-Mackie, E.J., Dwyer, N.K., Neufeld, E.B., Chang, T.Y., Liscum, L., Strauss, J.F. 3rd, Ohno, K., Zeigler, M., Carmi, R., Sokol, J., Markie, D., O'Neill, R.R., van Diggelen, O.P., Elleder, M., Patterson, M.C., Brady, R.O., Vanier, M.T., Pentchev, P.G., Tagle, D.A., Niemann-pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277 (1997), 228–231.
30. Cataldo, A.M., Hamilton, D.J., Nixon, R.A., Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res. 640 (1994), 68–80.
31. Cataldo, A.M., Hamilton, D.J., Barnett, J.L., Paskevich, P.A., Nixon, R.A., Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16 (1996), 186–199.
32. Cataldo, A.M., Peterhoff, C.M., Troncoso, J.C., Gomez-Isla, T., Hyman, B.T., Nixon, R.A., Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157 (2000), 277–286.
33. Cataldo, A.M., Mathews, P.M., Boiteau, A.B., Hassinger, L.C., Peterhoff, C.M., Jiang, Y., Mullaney, K., Neve, R.L., Gruenberg, J., Nixon, R.A., Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects. Am. J. Pathol. 173 (2008), 370–384.
34. Chandrachud, U., Walker, M.W., Simas, A.M., Heetveld, S., Petcherski, A., Klein, M., Oh, H., Wolf, P., Zhao, W.N., Norton, S., Haggarty, S.J., Lloyd-Evans, E., Cotman, S.L., Unbiased cell-based screening in a neuronal cell model of batten disease highlights an interaction between Ca2+ homeostasis, autophagy, and CLN3 protein function. J. Biol. Chem. 290 (2015), 14361–14380.
35. Charman, M., Kennedy, B.E., Osborne, N., Karten, B., MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J. Lipid Res. 51 (2010), 1023–1034.
36. Chen, C.S., Bach, G., Pagano, R.E., Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 6373–6378.
37. Chen, C.S., Patterson, M.C., Wheatley, C.L., O'Brien, J.F., Pagano, R.E., Broad screening test for sphingolipid-storage diseases. Lancet 354 (1999), 901–905.
38. Chiarelli, R., Roccheri, M.C., Heavy metals and metalloids as autophagy inducing agents: focus on cadmium and arsenic. Cells 1 (2012), 597–616.
39. Chiba, Y., Komori, H., Takei, S., Hasegawa-Ishii, S., Kawamura, N., Adachi, K., Nanba, E., Hosokawa, M., Enokido, Y., Kouchi, Z., Yoshida, F., Shimada, A., Niemann-pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem lewy bodies: an autopsy case. Neuropathology 34 (2014), 49–57.
40. Chin-Chan, M., Navarro-Yepes, J., Quintanilla-Vega, B., Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front. Cell Neurosci., 9, 2015, 124.
41. Choubey, A., Kalia, R.K., Malmstadt, N., Nakano, A., Vashishta, P., Cholesterol translocation in a phospholipid membrane. Biophys. J. 104 (2013), 2429–2436.
42. Choudhury, A., Dominguez, M., Puri, V., Sharma, D.K., Narita, K., Wheatley, C.L., Marks, D.L., Pagano, R.E., Rab proteins mediate golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-pick C cells. J. Clin. Invest. 109 (2002), 1541–1550.
43. Coelho, J.C., Sopelsa, A.M., Tobo, P.R., Severini, M.H., Silva, C.D., Giugliani, R., Biochemical studies on leukocyte and fibroblast human beta-galactosidase. Clin. Biochem. 32 (1999), 167–170.
44. Coen, K., Flannagan, R.S., Baron, S., Carraro-Lacroix, L.R., Wang, D., Vermeire, W., Michiels, C., Munck, S., Baert, V., Sugita, S., Wuytack, F., Hiesinger, P.R., Grinstein, S., Annaert, W., Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 198 (2012), 23–35.
45. Coffey, E.E., Beckel, J.M., Laties, A.M., Mitchell, C.H., Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 263 (2014), 111–124.
46. Cornutiu, G., The incidence and prevalence of Alzheimer's disease. Neurodegener. Dis. 8 (2011), 9–14.
47. Cossec, J.C., Marquer, C., Panchal, M., Lazar, A.N., Duyckaerts, C., Potier, M.C., Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim. Biophys. Acta 1801 (2010), 839–845.
48. Coutinho, M.F., Lacerda, L., Alves, S., Glycosaminoglycan storage disorders: a review. Biochem. Res. Int., 2012, 2012, 471325.
49. Cox, T.M., Cachon-Gonzalez, M.B., The cellular pathology of lysosomal diseases. J. Pathol. 226 (2012), 241–254.
50. Cuervo, A.M., Dice, J.F., When lysosomes get old. Exp. Gerontol. 35 (2000), 119–131.
51. Currinn, H., Guscott, B., Balklava, Z., Rothnie, A., Wassmer, T., APP controls the formation of PI(3, 5)P2 vesicles through its binding of the PIKfyve complex. Cell. Mol. Life Sci. 73 (2016), 393–408.
52. Davidson, C.D., Ali, N.F., Micsenyi, M.C., Stephney, G., Renault, S., Dobrenis, K., Ory, D.S., Vanier, M.T., Walkley, S.U., Chronic cyclodextrin treatment of murine Niemann-pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One, 4, 2009, e6951.
53. De Rosa, P., Marini, E.S., Gelmetti, V., Valente, E.M., Candidate genes for Parkinson disease: lessons from pathogenesis. Clin. Chim. Acta 449 (2015), 68–76.
54. Dehay, B., Ramirez, A., Martinez-Vicente, M., Perier, C., Canron, M.H., Doudnikoff, E., Vital, A., Vila, M., Klein, C., Bezard, E., Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 9611–9616.
55. Desikan, R.S., Schork, A.J., Wang, Y., Thompson, W.K., Dehghan, A., Ridker, P.M., Chasman, D.I., McEvoy, L.K., Holland, D., Chen, C.H., Karow, D.S., Brewer, J.B., Hess, C.P., Williams, J., Sims, R., O'Donovan, M.C., Choi, S.H., Bis, J.C., Ikram, M.A., Gudnason, V., DeStefano, A.L., van der Lee, S.J., Psaty, B.M., van Duijn, C.M., Launer, L., Seshadri, S., Pericak-Vance, M.A., Mayeux, R., Haines, J.L., Farrer, L.A., Hardy, J., Ulstein, I.D., Aarsland, D., Fladby, T., White, L.R., Sando, S.B., Rongve, A., Witoelar, A., Djurovic, S., Hyman, B.T., Snaedal, J., Steinberg, S., Stefansson, H., Stefansson, K., Schellenberg, G.D., Andreassen, O.A., Dale, A.M., Inflammation Working, G., International Genomics of Alzheimer's Disease, P., DemGene, I., Polygenic overlap between C-reactive protein, plasma lipids, and alzheimer disease. Circulation 131 (2015), 2061–2069.
56. Dickinson, G.D., Churchill, G.C., Brailoiu, E., Patel, S., Deviant nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated Ca2+ signaling upon lysosome proliferation. J. Biol. Chem. 285 (2010), 13321–13325.
57. Dickson, D.W., Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb. Perspect. Med., 2, 2012.
58. Djelti, F., Braudeau, J., Hudry, E., Dhenain, M., Varin, J., Bieche, I., Marquer, C., Chali, F., Ayciriex, S., Auzeil, N., Alves, S., Langui, D., Potier, M.C., Laprevote, O., Vidaud, M., Duyckaerts, C., Miles, R., Aubourg, P., Cartier, N., CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease. Brain 138 (2015), 2383–2398.
59. Dodson, M.W., Zhang, T., Jiang, C., Chen, S., Guo, M., Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning. Hum. Mol. Genet. 21 (2012), 1350–1363.
60. Duran, R., Mencacci, N.E., Angeli, A.V., Shoai, M., Deas, E., Houlden, H., Mehta, A., Hughes, D., Cox, T.M., Deegan, P., Schapira, A.H., Lees, A.J., Limousin, P., Jarman, P.R., Bhatia, K.P., Wood, N.W., Hardy, J., Foltynie, T., The glucocerobrosidase E326 K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease. Mov. Disord. 28 (2013), 232–236.
61. Eichelsdoerfer, J.L., Evans, J.A., Slaugenhaupt, S.A., Cuajungco, M.P., Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel. J. Biol. Chem. 285 (2010), 34304–34308.
62. Farlow, J., Pankratz, N.D., Wojcieszek, J., Foroud, T., Parkinson Disease Overview. Pagon, R.A., Adam, M.P., Ardinger, H.H., Wallace, S.E., Amemiya, A., Bean, L.J.H., Bird, T.D., Fong, C.T., Mefford, H.C., Smith, R.J.H., Stephens, K., (eds.), 1993, GeneReviews(R), Seattle (WA).
63. Feng, X., Huang, Y., Lu, Y., Xiong, J., Wong, C.O., Yang, P., Xia, J., Chen, D., Du, G., Venkatachalam, K., Xia, X., Zhu, M.X., Drosophila TRPML forms PI(3,5)P2-activated cation channels in both endolysosomes and plasma membrane. J. Biol. Chem. 289 (2014), 4262–4272.
64. Filippov, V., Song, M.A., Zhang, K., Vinters, H.V., Tung, S., Kirsch, W.M., Yang, J., Duerksen-Hughes, P.J., Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases. J. Alzheimers Dis. 29 (2012), 537–547.
65. Fu, R., Yanjanin, N.M., Elrick, M.J., Ware, C., Lieberman, A.P., Porter, F.D., Apolipoprotein E genotype and neurological disease onset in Niemann-pick disease, type C1. Am. J. Med. Genet. A 158A (2012), 2775–2780.
66. Gan-Or, Z., Dion, P.A., Rouleau, G.A., Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease. Autophagy 11 (2015), 1443–1457.
67. Gevry, N., Schoonjans, K., Guay, F., Murphy, B.D., Cholesterol supply and SREBPs modulate transcription of the Niemann-pick C-1 gene in steroidogenic tissues. J. Lipid Res. 49 (2008), 1024–1033.
68. Ginsberg, S.D., Galvin, J.E., Lee, V.M., Rorke, L.B., Dickson, D.W., Wolfe, J.H., Jones, M.Z., Trojanowski, J.Q., Accumulation of intracellular amyloid-beta peptide (A beta 1–40) in mucopolysaccharidosis brains. J. Neuropathol. Exp. Neurol. 58 (1999), 815–824.
69. Glabe, C., Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17 (2001), 137–145.
70. Goate, A., Chartier-Harlin, M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991), 704–706.
71. Golabek, A.A., Kida, E., Walus, M., Kaczmarski, W., Michalewski, M., Wisniewski, K.E., CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells. Mol. Genet. Metab. 70 (2000), 203–213.
72. Gomez-Suaga, P., Churchill, G.C., Patel, S., Hilfiker, S., A link between LRRK2, autophagy and NAADP-mediated endolysosomal calcium signalling. Biochem. Soc. Trans. 40 (2012), 1140–1146.
73. Gomez-Suaga, P., Rivero-Rios, P., Fdez, E., Blanca Ramirez, M., Ferrer, I., Aiastui, A., Lopez De Munain, A., Hilfiker, S., LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum. Mol. Genet. 23 (2014), 6779–6796.
74. Grbovic, O.M., Mathews, P.M., Jiang, Y., Schmidt, S.D., Dinakar, R., Summers-Terio, N.B., Ceresa, B.P., Nixon, R.A., Cataldo, A.M., Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J. Biol. Chem. 278 (2003), 31261–31268.
75. Grimm, M.O., Zinser, E.G., Grosgen, S., Hundsdorfer, B., Rothhaar, T.L., Burg, V.K., Kaestner, L., Bayer, T.A., Lipp, P., Muller, U., Grimm, H.S., Hartmann, T., Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism. PLoS One, 7, 2012, e34095.
76. Grubman, A., Pollari, E., Duncan, C., Caragounis, A., Blom, T., Volitakis, I., Wong, A., Cooper, J., Crouch, P.J., Koistinaho, J., Jalanko, A., White, A.R., Kanninen, K.M., Deregulation of biometal homeostasis: the missing link for neuronal ceroid lipofuscinoses?. Metallomics 6 (2014), 932–943.
77. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., Golenbock, D.T., The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9 (2008), 857–865.
78. Hampshire, D.J., Roberts, E., Crow, Y., Bond, J., Mubaidin, A., Wriekat, A.L., Al-Din, A., Woods, C.G., Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J. Med. Genet. 38 (2001), 680–682.
79. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A., Morgan, A.R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M.K., Brayne, C., Rubinsztein, D.C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K.S., Passmore, P.A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A.D., Love, S., Kehoe, P.G., Hardy, J., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., Heun, R., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A.M., Kauwe, J.S., Cruchaga, C., Nowotny, P., Morris, J.C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Livingston, G., Bass, N.J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C.E., Tsolaki, M., Singleton, A.B., Guerreiro, R., Muhleisen, T.W., Nothen, M.M., Moebus, S., Jockel, K.H., Klopp, N., Wichmann, H.E., Carrasquillo, M.M., Pankratz, V.S., Younkin, S.G., Holmans, P.A., O'Donovan, M., Owen, M.J., Williams, J., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41 (2009), 1088–1093.
80. Hockey, L.N., Kilpatrick, B.S., Eden, E.R., Lin-Moshier, Y., Brailoiu, G.C., Brailoiu, E., Futter, C.E., Schapira, A.H., Marchant, J.S., Patel, S., Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition. J. Cell Sci. 128 (2015), 232–238.
81. Holemans, T., Sorensen, D.M., van Veen, S., Martin, S., Hermans, D., Kemmer, G.C., Van den Haute, C., Baekelandt, V., Gunther Pomorski, T., Agostinis, P., Wuytack, F., Palmgren, M., Eggermont, J., Vangheluwe, P., A lipid switch unlocks Parkinson's disease-associated ATP13A2. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 9040–9045.
82. Holopainen, J.M., Saarikoski, J., Kinnunen, P.K., Jarvela, I., Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). Eur. J. Biochem. 268 (2001), 5851–5856.
83. Holtta-Vuori, M., Tanhuanpaa, K., Mobius, W., Somerharju, P., Ikonen, E., Modulation of cellular cholesterol transport and homeostasis by Rab11. Mol. Biol. Cell 13 (2002), 3107–3122.
84. Hopfner, F., Schulte, E.C., Mollenhauer, B., Bereznai, B., Knauf, F., Lichtner, P., Zimprich, A., Haubenberger, D., Pirker, W., Brucke, T., Peters, A., Gieger, C., Kuhlenbaumer, G., Trenkwalder, C., Winkelmann, J., The role of SCARB2 as susceptibility factor in Parkinson's disease. Mov. Disord. 28 (2013), 538–540.
85. Huynh, K.K., Gershenzon, E., Grinstein, S., Cholesterol accumulation by macrophages impairs phagosome maturation. J. Biol. Chem. 283 (2008), 35745–35755.
86. Ikeda, K., Hirayama, M., Hirota, Y., Asa, E., Seki, J., Tanaka, Y., Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes. Biochem. Biophys. Res. Commun. 377 (2008), 268–274.
87. Ioannou, Y.A., Guilty until proven innocent: the case of NPC1 and cholesterol. Trends Biochem. Sci. 30 (2005), 498–505.
88. Jeyakumar, M., Williams, I., Smith, D., Cox, T.M., Platt, F.M., Critical role of iron in the pathogenesis of the murine gangliosidoses. Neurobiol. Dis. 34 (2009), 406–416.
89. Ji, Z.S., Mullendorff, K., Cheng, I.H., Miranda, R.D., Huang, Y., Mahley, R.W., Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. J. Biol. Chem. 281 (2006), 2683–2692.
90. Jiang, R., Diaz-Castro, B., Looger, L.L., Khakh, B.S., Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington's disease model mice. J. Neurosci. 36 (2016), 3453–3470.
91. Jin, L.W., Shie, F.S., Maezawa, I., Vincent, I., Bird, T., Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-pick type C defects is associated with endosomal abnormalities. Am. J. Pathol. 164 (2004), 975–985.
92. Johnson, D.E., Ostrowski, P., Jaumouille, V., Grinstein, S., The position of lysosomes within the cell determines their luminal pH. J. Cell Biol. 212 (2016), 677–692.
93. Jolly, R.D., Dalefield, R.R., Palmer, D.N., Ceroid, lipofuscin and the ceroid-lipofuscinoses (Batten disease). J. Inherit. Metab. Dis. 16 (1993), 280–283.
94. Jolly, R.D., Palmer, D.N., Dalefield, R.R., The analytical approach to the nature of lipofuscin (age pigment). Arch. Gerontol. Geriatr. 34 (2002), 205–217.
95. Jones, L., Holmans, P.A., Hamshere, M.L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Pahwa, J.S., Jones, N., Stretton, A., Morgan, A.R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M.K., Brayne, C., Rubinsztein, D.C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K.S., Passmore, P.A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A.D., Love, S., Kehoe, P.G., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., Heun, R., Kolsch, H., van den Bussche, H., Heuser, I., Peters, O., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A.M., Kauwe, J.S., Cruchaga, C., Nowotny, P., Morris, J.C., Mayo, K., Livingston, G., Bass, N.J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C.E., Singleton, A.B., Guerreiro, R., Muhleisen, T.W., Nothen, M.M., Moebus, S., Jockel, K.H., Klopp, N., Wichmann, H.E., Ruther, E., Carrasquillo, M.M., Pankratz, V.S., Younkin, S.G., Hardy, J., O'Donovan, M.C., Owen, M.J., Williams, J., Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One, 5, 2010, e13950.
96. Kagedal, K., Kim, W.S., Appelqvist, H., Chan, S., Cheng, D., Agholme, L., Barnham, K., McCann, H., Halliday, G., Garner, B., Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease. Biochim. Biophys. Acta 1801 (2010), 831–838.
97. Kageyama, T., Structure and function of cathepsin E, a candidate for processing proteinases. Tanpakushitsu Kakusan Koso 41 (1996), 347–355.
98. Kaptzan, T., West, S.A., Holicky, E.L., Wheatley, C.L., Marks, D.L., Wang, T., Peake, K.B., Vance, J., Walkley, S.U., Pagano, R.E., Development of a Rab9 transgenic mouse and its ability to increase the lifespan of a murine model of Niemann-pick type C disease. Am. J. Pathol. 174 (2009), 14–20.
99. Kasper, D., Planells-Cases, R., Fuhrmann, J.C., Scheel, O., Zeitz, O., Ruether, K., Schmitt, A., Poet, M., Steinfeld, R., Schweizer, M., Kornak, U., Jentsch, T.J., Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24 (2005), 1079–1091.
100. Kaufmann, A.M., Krise, J.P., Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J. Pharm. Sci. 96 (2007), 729–746.
101. Kaufmann, A.M., Krise, J.P., Niemann-pick C1 functions in regulating lysosomal amine content. J. Biol. Chem. 283 (2008), 24584–24593.
102. Keilani, S., Lun, Y., Stevens, A.C., Williams, H.N., Sjoberg, E.R., Khanna, R., Valenzano, K.J., Checler, F., Buxbaum, J.D., Yanagisawa, K., Lockhart, D.J., Wustman, B.A., Gandy, S., Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-beta peptide. J. Neurosci. 32 (2012), 5223–5236.
103. Kempster, P.A., Hurwitz, B., Lees, A.J., A new look at james Parkinson's essay on the shaking palsy. Neurology 69 (2007), 482–485.
104. Khurana, V., Elson-Schwab, I., Fulga, T.A., Sharp, K.A., Loewen, C.A., Mulkearns, E., Tyynela, J., Scherzer, C.R., Feany, M.B., Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet., 6, 2010, e1001026.
105. Kilpatrick, B.S., Magalhaes, J., Beavan, M.S., McNeill, A., Gegg, M.E., Cleeter, M.W., Bloor-Young, D., Churchill, G.C., Duchen, M.R., Schapira, A.H., Patel, S., Endoplasmic reticulum and lysosomal Ca(2 + ) stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts. Cell Calcium 59 (2016), 12–20.
106. Kirschke, H., Wiederanders, B., Bromme, D., Rinne, A., Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem. J. 264 (1989), 467–473.
107. Knight, E.M., Williams, H.N., Stevens, A.C., Kim, S.H., Kottwitz, J.C., Morant, A.D., Steele, J.W., Klein, W.L., Yanagisawa, K., Boyd, R.E., Lockhart, D.J., Sjoberg, E.R., Ehrlich, M.E., Wustman, B.A., Gandy, S., Evidence that small molecule enhancement of beta-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Abeta. Mol. Psychiatry 20 (2015), 109–117.
108. Kodam, A., Maulik, M., Peake, K., Amritraj, A., Vetrivel, K.S., Thinakaran, G., Vance, J.E., Kar, S., Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-pick type C1-deficient mouse brains. Glia 58 (2010), 1267–1281.
109. Koga, H., Yamada, H., Nishimura, Y., Kato, K., Imoto, T., Multiple proteolytic action of rat liver cathepsin B: specificities and pH-dependences of the endo- and exopeptidase activities. J. Biochem. 110 (1991), 179–188.
110. Kong, S.M., Chan, B.K., Park, J.S., Hill, K.J., Aitken, J.B., Cottle, L., Farghaian, H., Cole, A.R., Lay, P.A., Sue, C.M., Cooper, A.A., Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes alpha-Synuclein externalization via exosomes. Hum. Mol. Genet. 23 (2014), 2816–2833.
111. Korkotian, E., Schwarz, A., Pelled, D., Schwarzmann, G., Segal, M., Futerman, A.H., Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 274 (1999), 21673–21678.
112. Kovacs, A.D., Weimer, J.M., Pearce, D.A., Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiol. Dis. 22 (2006), 575–585.
113. Kovacs, G.G., Gelpi, E., Strobel, T., Ricken, G., Nyengaard, J.R., Bernheimer, H., Budka, H., Involvement of the endosomal-lysosomal system correlates with regional pathology in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 66 (2007), 628–636.
114. Lachmann, R.H., te Vruchte, D., Lloyd-Evans, E., Reinkensmeier, G., Sillence, D.J., Fernandez-Guillen, L., Dwek, R.A., Butters, T.D., Cox, T.M., Platt, F.M., Treatment with miglustat reverses the lipid-trafficking defect in Niemann-pick disease type C. Neurobiol. Dis. 16 (2004), 654–658.
115. Lauritzen, I., Pardossi-Piquard, R., Bourgeois, A., Pagnotta, S., Biferi, M.G., Barkats, M., Lacor, P., Klein, W., Bauer, C., Checler, F., Intraneuronal aggregation of the beta-CTF fragment of APP (C99) induces Abeta-independent lysosomal-autophagic pathology. Acta Neuropathol., 2016.
116. Lee, J.H., Yu, W.H., Kumar, A., Lee, S., Mohan, P.S., Peterhoff, C.M., Wolfe, D.M., Martinez-Vicente, M., Massey, A.C., Sovak, G., Uchiyama, Y., Westaway, D., Cuervo, A.M., Nixon, R.A., Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141 (2010), 1146–1158.
117. Lee, J.K., Jin, H.K., Park, M.H., Kim, B.R., Lee, P.H., Nakauchi, H., Carter, J.E., He, X., Schuchman, E.H., Bae, J.S., Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's disease. J. Exp. Med. 211 (2014), 1551–1570.
118. Lee, J.H., McBrayer, M.K., Wolfe, D.M., Haslett, L.J., Kumar, A., Sato, Y., Lie, P.P., Mohan, P., Coffey, E.E., Kompella, U., Mitchell, C.H., Lloyd-Evans, E., Nixon, R.A., Presenilin 1 maintains lysosomal Ca(2 + ) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep. 12 (2015), 1430–1444.
119. Letiembre, M., Liu, Y., Walter, S., Hao, W., Pfander, T., Wrede, A., Schulz-Schaeffer, W., Fassbender, K., Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging 30 (2009), 759–768.
120. Lewen, A., Matz, P., Chan, P.H., Free radical pathways in CNS injury. J. Neurotrauma 17 (2000), 871–890.
121. Li, L., Wang, X., Fei, X., Xia, L., Qin, Z., Liang, Z., Parkinson's disease involves autophagy and abnormal distribution of cathepsin L. Neurosci. Lett. 489 (2011), 62–67.
122. Liu, Q., Zerbinatti, C.V., Zhang, J., Hoe, H.S., Wang, B., Cole, S.L., Herz, J., Muglia, L., Bu, G., Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56 (2007), 66–78.
123. Liu, J., Lu, W., Reigada, D., Nguyen, J., Laties, A.M., Mitchell, C.H., Restoration of lysosomal pH in RPE cells from cultured human and ABCA4(-/-) mice: pharmacologic approaches and functional recovery. Invest. Ophthalmol. Vis. Sci. 49 (2008), 772–780.
124. Lloyd-Evans, E., Platt, F.M., Lipids on trial: the search for the offending metabolite in Niemann-pick type C disease. Traffic 11 (2010), 419–428.
125. Lloyd-Evans, E., Platt, F.M., Lysosomal Ca(2 + ) homeostasis: role in pathogenesis of lysosomal storage diseases. Cell Calcium 50 (2011), 200–205.
126. Lloyd-Evans, E., Pelled, D., Riebeling, C., Bodennec, J., de-Morgan, A., Waller, H., Schiffmann, R., Futerman, A.H., Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J. Biol. Chem. 278 (2003), 23594–23599.
127. Lloyd-Evans, E., Pelled, D., Riebeling, C., Futerman, A.H., Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms. Biochem. J. 375 (2003), 561–565.
128. Lloyd-Evans, E., Morgan, A.J., He, X., Smith, D.A., Elliot-Smith, E., Sillence, D.J., Churchill, G.C., Schuchman, E.H., Galione, A., Platt, F.M., Niemann-pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 14 (2008), 1247–1255.
129. Lloyd-Evans, E., Waller-Evans, H., Peterneva, K., Platt, F.M., Endolysosomal calcium regulation and disease. Biochem. Soc. Trans. 38 (2010), 1458–1464.
130. MacLeod, D.A., Rhinn, H., Kuwahara, T., Zolin, A., Di Paolo, G., McCabe, B.D., Marder, K.S., Honig, L.S., Clark, L.N., Small, S.A., Abeliovich, A., RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 77 (2013), 425–439.
131. Mahley, R.W., Weisgraber, K.H., Huang, Y., Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 5644–5651.
132. Majumdar, A., Capetillo-Zarate, E., Cruz, D., Gouras, G.K., Maxfield, F.R., Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes. Mol. Biol. Cell 22 (2011), 1664–1676.
133. Malakouti-Nejad, M., Shahidi, G.A., Rohani, M., Shojaee, S.M., Hashemi, M., Klotzle, B., Fan, J.B., Elahi, E., Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features. Neurosci. Lett. 577 (2014), 106–111.
134. Malathi, K., Higaki, K., Tinkelenberg, A.H., Balderes, D.A., Almanzar-Paramio, D., Wilcox, L.J., Erdeniz, N., Redican, F., Padamsee, M., Liu, Y., Khan, S., Alcantara, F., Carstea, E.D., Morris, J.A., Sturley, S.L., Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution. J. Cell Biol. 164 (2004), 547–556.
135. Malnar, M., Hecimovic, S., Mattsson, N., Zetterberg, H., Bidirectional links between Alzheimer's disease and Niemann-pick type C disease. Neurobiol. Dis. 72 (2014), 37–47 Pt A.
136. Mattson, M.P., Calcium and neurodegeneration. Aging Cell 6 (2007), 337–350.
137. Mattsson, N., Zetterberg, H., Bianconi, S., Yanjanin, N.M., Fu, R., Mansson, J.E., Porter, F.D., Blennow, K., Gamma-secretase-dependent amyloid-beta is increased in Niemann-pick type C: a cross-sectional study. Neurology 76 (2011), 366–372.
138. Mattsson, N., Olsson, M., Gustavsson, M.K., Kosicek, M., Malnar, M., Mansson, J.E., Blomqvist, M., Gobom, J., Andreasson, U., Brinkmalm, G., Vite, C., Hecimovic, S., Hastings, C., Blennow, K., Zetterberg, H., Portelius, E., Amyloid-beta metabolism in Niemann-pick C disease models and patients. Metab. Brain Dis. 27 (2012), 573–585.
139. Maulik, M., Peake, K., Chung, J., Wang, Y., Vance, J.E., Kar, S., APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease. Hum. Mol. Genet. 24 (2015), 7132–7150.
140. Mazzulli, J.R., Xu, Y.H., Sun, Y., Knight, A.L., McLean, P.J., Caldwell, G.A., Sidransky, E., Grabowski, G.A., Krainc, D., Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146 (2011), 37–52.
141. McBrayer, M., Nixon, R.A., Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime. Biochem. Soc. Trans. 41 (2013), 1495–1502.
142. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., Klunk, W.E., Koroshetz, W.J., Manly, J.J., Mayeux, R., Mohs, R.C., Morris, J.C., Rossor, M.N., Scheltens, P., Carrillo, M.C., Thies, B., Weintraub, S., Phelps, C.H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7 (2011), 263–269.
143. Mullin, S., Schapira, A., The genetics of Parkinson's disease. Br. Med. Bull. 114 (2015), 39–52.
144. Murphy, K.E., Cottle, L., Gysbers, A.M., Cooper, A.A., Halliday, G.M., ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with lewy bodies. Acta Neuropathol. Commun., 1, 2013, 11.
145. Naj, A.C., Jun, G., Beecham, G.W., Wang, L.S., Vardarajan, B.N., Buros, J., Gallins, P.J., Buxbaum, J.D., Jarvik, G.P., Crane, P.K., Larson, E.B., Bird, T.D., Boeve, B.F., Graff-Radford, N.R., De Jager, P.L., Evans, D., Schneider, J.A., Carrasquillo, M.M., Ertekin-Taner, N., Younkin, S.G., Cruchaga, C., Kauwe, J.S., Nowotny, P., Kramer, P., Hardy, J., Huentelman, M.J., Myers, A.J., Barmada, M.M., Demirci, F.Y., Baldwin, C.T., Green, R.C., Rogaeva, E., St George-Hyslop, P., Arnold, S.E., Barber, R., Beach, T., Bigio, E.H., Bowen, J.D., Boxer, A., Burke, J.R., Cairns, N.J., Carlson, C.S., Carney, R.M., Carroll, S.L., Chui, H.C., Clark, D.G., Corneveaux, J., Cotman, C.W., Cummings, J.L., DeCarli, C., DeKosky, S.T., Diaz-Arrastia, R., Dick, M., Dickson, D.W., Ellis, W.G., Faber, K.M., Fallon, K.B., Farlow, M.R., Ferris, S., Frosch, M.P., Galasko, D.R., Ganguli, M., Gearing, M., Geschwind, D.H., Ghetti, B., Gilbert, J.R., Gilman, S., Giordani, B., Glass, J.D., Growdon, J.H., Hamilton, R.L., Harrell, L.E., Head, E., Honig, L.S., Hulette, C.M., Hyman, B.T., Jicha, G.A., Jin, L.W., Johnson, N., Karlawish, J., Karydas, A., Kaye, J.A., Kim, R., Koo, E.H., Kowall, N.W., Lah, J.J., Levey, A.I., Lieberman, A.P., Lopez, O.L., Mack, W.J., Marson, D.C., Martiniuk, F., Mash, D.C., Masliah, E., McCormick, W.C., McCurry, S.M., McDavid, A.N., McKee, A.C., Mesulam, M., Miller, B.L., et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43 (2011), 436–441.
146. Nalls, M.A., Duran, R., Lopez, G., Kurzawa-Akanbi, M., McKeith, I.G., Chinnery, P.F., Morris, C.M., Theuns, J., Crosiers, D., Cras, P., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Mann, D.M., Snowden, J., Pickering-Brown, S., Halliwell, N., Davidson, Y., Gibbons, L., Harris, J., Sheerin, U.M., Bras, J., Hardy, J., Clark, L., Marder, K., Honig, L.S., Berg, D., Maetzler, W., Brockmann, K., Gasser, T., Novellino, F., Quattrone, A., Annesi, G., De Marco, E.V., Rogaeva, E., Masellis, M., Black, S.E., Bilbao, J.M., Foroud, T., Ghetti, B., Nichols, W.C., Pankratz, N., Halliday, G., Lesage, S., Klebe, S., Durr, A., Duyckaerts, C., Brice, A., Giasson, B.I., Trojanowski, J.Q., Hurtig, H.I., Tayebi, N., Landazabal, C., Knight, M.A., Keller, M., Singleton, A.B., Wolfsberg, T.G., Sidransky, E., A multicenter study of glucocerebrosidase mutations in dementia with lewy bodies. JAMA Neurol. 70 (2013), 727–735.
147. Nelson, O., Supnet, C., Liu, H., Bezprozvanny, I., Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. J. Alzheimers Dis. 21 (2010), 781–793.
148. Neudorfer, O., Giladi, N., Elstein, D., Abrahamov, A., Turezkite, T., Aghai, E., Reches, A., Bembi, B., Zimran, A., Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 89 (1996), 691–694.
149. Nixon, R.A., Niemann-pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up. Am. J. Pathol. 164 (2004), 757–761.
150. Nixon, R.A., Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol. Aging 26 (2005), 373–382.
151. Nixon, R.A., Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 120 (2007), 4081–4091.
152. Nuytemans, K., Theuns, J., Cruts, M., Van Broeckhoven, C., Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum. Mutat. 31 (2010), 763–780.
153. O'Callaghan, P., Noborn, F., Sehlin, D., Li, J.P., Lannfelt, L., Lindahl, U., Zhang, X., Apolipoprotein E increases cell association of amyloid-beta 40 through heparan sulfate and LRP1 dependent pathways. Amyloid 21 (2014), 76–87.
154. Ohm, T.G., Treiber-Held, S., Distl, R., Glockner, F., Schonheit, B., Tamanai, M., Meske, V., Cholesterol and tau protein–findings in Alzheimer's and Niemann Pick C's disease. Pharmacopsychiatry 36:Suppl. 2 (2003), S120–S126.
155. Oikawa, N., Matsubara, T., Fukuda, R., Yasumori, H., Hatsuta, H., Murayama, S., Sato, T., Suzuki, A., Yanagisawa, K., Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus. PLoS One, 10, 2015, e0121356.
156. Ottis, P., Koppe, K., Onisko, B., Dynin, I., Arzberger, T., Kretzschmar, H., Requena, J.R., Silva, C.J., Huston, J.P., Korth, C., Human and rat brain lipofuscin proteome. Proteomics 12 (2012), 2445–2454.
157. Pacheco, C.D., Elrick, M.J., Lieberman, A.P., Tau deletion exacerbates the phenotype of Niemann-pick type C mice and implicates autophagy in pathogenesis. Hum. Mol. Genet. 18 (2009), 956–965.
158. Pagano, R.E., Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 (2003), 885–891.
159. Pan, L.S., Wang, Z., Ding, D., Zhu, X.P., Leng, H.L., Deng, X.B., Xu, Y.M., Lack of association between the ATP13A2 A746T variant and Parkinson's disease susceptibility in Han Chinese: a meta-analysis. Int. J. Neurosci., 2015, 1–7.
160. Park, J.S., Koentjoro, B., Veivers, D., Mackay-Sim, A., Sue, C.M., Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction. Hum. Mol. Genet. 23 (2014), 2802–2815.
161. Park, J.S., Blair, N.F., Sue, C.M., The role of ATP13A2 in Parkinson's disease: clinical phenotypes and molecular mechanisms. Mov. Disord. 30 (2015), 770–779.
162. Pastores, G.M., Hughes, D.A., Gaucher Disease. Pagon, R.A., Adam, M.P., Ardinger, H.H., Wallace, S.E., Amemiya, A., Bean, L.J.H., Bird, T.D., Fong, C.T., Mefford, H.C., Smith, R.J.H., Stephens, K., (eds.), 1993, GeneReviews(R), Seattle (WA).
163. Patel, S., Function and dysfunction of two-pore channels. Sci. Signal., 8, 2015, re7.
164. Pelled, D., Lloyd-Evans, E., Riebeling, C., Jeyakumar, M., Platt, F.M., Futerman, A.H., Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J. Biol. Chem. 278 (2003), 29496–29501.
165. Pelled, D., Trajkovic-Bodennec, S., Lloyd-Evans, E., Sidransky, E., Schiffmann, R., Futerman, A.H., Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol. Dis. 18 (2005), 83–88.
166. Penny, C.J., Kilpatrick, B.S., Eden, E.R., Patel, S., Coupling acidic organelles with the ER through Ca(2)(+) microdomains at membrane contact sites. Cell Calcium 58 (2015), 387–396.
167. Pentchev, P.G., Brady, R.O., Hibbert, S.R., Gal, A.E., Shapiro, D., Isolation and characterization of glucocerebrosidase from human placental tissue. J. Biol. Chem. 248 (1973), 5256–5261.
168. Pereira, V.G., Gazarini, M.L., Rodrigues, L.C., da Silva, F.H., Han, S.W., Martins, A.M., Tersariol, I.L., D'Almeida, V., Evidence of lysosomal membrane permeabilization in mucopolysaccharidosis type I: rupture of calcium and proton homeostasis. J. Cell Physiol. 223 (2010), 335–342.
169. Pernber, Z., Blennow, K., Bogdanovic, N., Mansson, J.E., Blomqvist, M., Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 33 (2012), 174–188.
170. Piper, R.C., Luzio, J.P., CUPpling calcium to lysosomal biogenesis. Trends Cell Biol. 14 (2004), 471–473.
171. Platt, F.M., Boland, B., van der Spoel, A.C., The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J. Cell Biol. 199 (2012), 723–734.
172. Platt, F.M., Sphingolipid lysosomal storage disorders. Nature 510 (2014), 68–75.
173. Pryor, P.R., Mullock, B.M., Bright, N.A., Gray, S.R., Luzio, J.P., The role of intraorganellar Ca(2 + ) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149 (2000), 1053–1062.
174. Puri, V., Watanabe, R., Dominguez, M., Sun, X., Wheatley, C.L., Marks, D.L., Pagano, R.E., Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat. Cell Biol. 1 (1999), 386–388.
175. Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L.P., Goebel, I., Mubaidin, A.F., Wriekat, A.L., Roeper, J., Al-Din, A., Hillmer, A.M., Karsak, M., Liss, B., Woods, C.G., Behrens, M.I., Kubisch, C., Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38 (2006), 1184–1191.
176. Ramonet, D., Podhajska, A., Stafa, K., Sonnay, S., Trancikova, A., Tsika, E., Pletnikova, O., Troncoso, J.C., Glauser, L., Moore, D.J., PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum. Mol. Genet. 21 (2012), 1725–1743.
177. Raux, G., Guyant-Marechal, L., Martin, C., Bou, J., Penet, C., Brice, A., Hannequin, D., Frebourg, T., Campion, D., Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J. Med. Genet. 42 (2005), 793–795.
178. Raychowdhury, M.K., Gonzalez-Perrett, S., Montalbetti, N., Timpanaro, G.A., Chasan, B., Goldmann, W.H., Stahl, S., Cooney, A., Goldin, E., Cantiello, H.F., Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum. Mol. Genet. 13 (2004), 617–627.
179. Regier, D.S., Tifft, C.J., GLB1-Related Disorders. Pagon, R.A., Adam, M.P., Ardinger, H.H., Wallace, S.E., Amemiya, A., Bean, L.J.H., Bird, T.D., Fong, C.T., Mefford, H.C., Smith, R.J.H., Stephens, K., (eds.), 1993, GeneReviews(R), Seattle (WA).
180. Rentschler, G., Covolo, L., Haddad, A.A., Lucchini, R.G., Zoni, S., Broberg, K., ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese. Neurotoxicology 33 (2012), 697–702.
181. Ruas, M., Rietdorf, K., Arredouani, A., Davis, L.C., Lloyd-Evans, E., Koegel, H., Funnell, T.M., Morgan, A.J., Ward, J.A., Watanabe, K., Cheng, X., Churchill, G.C., Zhu, M.X., Platt, F.M., Wessel, G.M., Parrington, J., Galione, A., Purified TPC isoforms form NAADP receptors with distinct roles for Ca(2 + ) signaling and endolysosomal trafficking. Curr. Biol., 2010.
182. Saez, P.J., Orellana, J.A., Vega-Riveros, N., Figueroa, V.A., Hernandez, D.E., Castro, J.F., Klein, A.D., Jiang, J.X., Zanlungo, S., Saez, J.C., Disruption in connexin-based communication is associated with intracellular Ca(2)(+) signal alterations in astrocytes from Niemann-pick type C mice. PLoS One, 8, 2013, e71361.
183. Saito, Y., Suzuki, K., Nanba, E., Yamamoto, T., Ohno, K., Murayama, S., Niemann-pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity. Ann. Neurol. 52 (2002), 351–355.
184. Sandhoff, K., Harzer, K., Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J. Neurosci. 33 (2013), 10195–10208.
185. Sardi, S.P., Cheng, S.H., Shihabuddin, L.S., Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle. Prog. Neurobiol. 125 (2015), 47–62.
186. Schmidt, K., Wolfe, D.M., Stiller, B., Pearce, D.A., Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2. Biochem. Biophys. Res. Commun. 383 (2009), 198–202.
187. Schneider, S.A., Paisan-Ruiz, C., Quinn, N.P., Lees, A.J., Houlden, H., Hardy, J., Bhatia, K.P., ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov. Disord. 25 (2010), 979–984.
188. Schondorf, D.C., Aureli, M., McAllister, F.E., Hindley, C.J., Mayer, F., Schmid, B., Sardi, S.P., Valsecchi, M., Hoffmann, S., Schwarz, L.K., Hedrich, U., Berg, D., Shihabuddin, L.S., Hu, J., Pruszak, J., Gygi, S.P., Sonnino, S., Gasser, T., Deleidi, M., iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun., 5, 2014, 4028.
189. Schueler, U.H., Kolter, T., Kaneski, C.R., Zirzow, G.C., Sandhoff, K., Brady, R.O., Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease. J. Inherit. Metab. Dis. 27 (2004), 649–658.
190. Sevin, M., Lesca, G., Baumann, N., Millat, G., Lyon-Caen, O., Vanier, M.T., Sedel, F., The adult form of Niemann-pick disease type C. Brain 130 (2007), 120–133.
191. Shachar, T., Lo Bianco, C., Recchia, A., Wiessner, C., Raas-Rothschild, A., Futerman, A.H., Lysosomal storage disorders and Parkinson's disease: gaucher disease and beyond. Mov. Disord. 26 (2011), 1593–1604.
192. Sharon, R., Bar-Joseph, I., Mirick, G.E., Serhan, C.N., Selkoe, D.J., Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies. J. Biol. Chem. 278 (2003), 49874–49881.
193. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R.J., Wasco, W., Da Silva, H.A., Haines, J.L., Perkicak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P.E., Rommens, J.M., St George-Hyslop, P.H., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995), 754–760.
194. Shi, F., Yang, L., Kouadir, M., Yang, Y., Wang, J., Zhou, X., Yin, X., Zhao, D., The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation. J. Neuroinflammation, 9, 2012, 73.
195. Sidransky, E., Nalls, M.A., Aasly, J.O., Aharon-Peretz, J., Annesi, G., Barbosa, E.R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., Chen, C.M., Clark, L.N., Condroyer, C., De Marco, E.V., Durr, A., Eblan, M.J., Fahn, S., Farrer, M.J., Fung, H.C., Gan-Or, Z., Gasser, T., Gershoni-Baruch, R., Giladi, N., Griffith, A., Gurevich, T., Januario, C., Kropp, P., Lang, A.E., Lee-Chen, G.J., Lesage, S., Marder, K., Mata, I.F., Mirelman, A., Mitsui, J., Mizuta, I., Nicoletti, G., Oliveira, C., Ottman, R., Orr-Urtreger, A., Pereira, L.V., Quattrone, A., Rogaeva, E., Rolfs, A., Rosenbaum, H., Rozenberg, R., Samii, A., Samaddar, T., Schulte, C., Sharma, M., Singleton, A., Spitz, M., Tan, E.K., Tayebi, N., Toda, T., Troiano, A.R., Tsuji, S., Wittstock, M., Wolfsberg, T.G., Wu, Y.R., Zabetian, C.P., Zhao, Y., Ziegler, S.G., Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361 (2009), 1651–1661.
196. Siintola, E., Partanen, S., Stromme, P., Haapanen, A., Haltia, M., Maehlen, J., Lehesjoki, A.E., Tyynela, J., Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129 (2006), 1438–1445.
197. Sillence, D.J., Glucosylceramide modulates endolysosomal pH in Gaucher disease. Mol. Genet. Metab. 109 (2013), 194–200.
198. Sleat, D.E., Wiseman, J.A., El-Banna, M., Price, S.M., Verot, L., Shen, M.M., Tint, G.S., Vanier, M.T., Walkley, S.U., Lobel, P., Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 5886–5891.
199. Smith, D., Wallom, K.L., Williams, I.M., Jeyakumar, M., Platt, F.M., Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-pick disease type C1. Neurobiol. Dis. 36 (2009), 242–251.
200. Snider, B.J., Fagan, A.M., Roe, C., Shah, A.R., Grant, E.A., Xiong, C., Morris, J.C., Holtzman, D.M., Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type. Arch. Neurol. 66 (2009), 638–645.
201. Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, R.T., Kimata, K., Koike, Y., Wight, T.N., Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137 (1990), 1253–1270.
202. Society, A.s., 2014. Dementia 2014 report statistics, https://www.alzheimers.org.uk/statistics.
203. Sonderfeld, S., Conzelmann, E., Schwarzmann, G., Burg, J., Hinrichs, U., Sandhoff, K., Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects. Eur. J. Biochem. 149 (1985), 247–255.
204. Soyombo, A.A., Tjon-Kon-Sang, S., Rbaibi, Y., Bashllari, E., Bisceglia, J., Muallem, S., Kiselyov, K., TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J. Biol. Chem. 281 (2006), 7294–7301.
205. Spies, P.E., Slats, D., Sjogren, J.M., Kremer, B.P., Verhey, F.R., Rikkert, M.G., Verbeek, M.M., The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Curr. Alzheimer Res. 7 (2010), 470–476.
206. Staretz-Chacham, O., Choi, J.H., Wakabayashi, K., Lopez, G., Sidransky, E., Psychiatric and behavioral manifestations of lysosomal storage disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (2010), 1253–1265.
207. Steger, M., Tonelli, F., Ito, G., Davies, P., Trost, M., Vetter, M., Wachter, S., Lorentzen, E., Duddy, G., Wilson, S., Baptista, M.A., Fiske, B.K., Fell, M.J., Morrow, J.A., Reith, A.D., Alessi, D.R., Mann, M., Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases. Elife, 5, 2016.
208. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., Roses, A.D., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 1977–1981.
209. Suzuki, K., Parker, C.C., Pentchev, P.G., Katz, D., Ghetti, B., D'Agostino, A.N., Carstea, E.D., Neurofibrillary tangles in Niemann-pick disease type C. Acta Neuropathol. 89 (1995), 227–238.
210. Tan, J., Zhang, T., Jiang, L., Chi, J., Hu, D., Pan, Q., Wang, D., Zhang, Z., Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. J. Biol. Chem. 286 (2011), 29654–29662.
211. Thimiri Govinda Raj, D.B., Ghesquiere, B., Tharkeshwar, A.K., Coen, K., Derua, R., Vanderschaeghe, D., Rysman, E., Bagadi, M., Baatsen, P., De Strooper, B., Waelkens, E., Borghs, G., Callewaert, N., Swinnen, J., Gevaert, K., Annaert, W., A novel strategy for the comprehensive analysis of the biomolecular composition of isolated plasma membranes. Mol. Syst. Biol., 7, 2011, 541.
212. Trombetta, E.S., Ebersold, M., Garrett, W., Pypaert, M., Mellman, I., Activation of lysosomal function during dendritic cell maturation. Science 299 (2003), 1400–1403.
213. Tsunemi, T., Krainc, D., Zn(2)(+) dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum. Mol. Genet. 23 (2014), 2791–2801.
214. Usenovic, M., Tresse, E., Mazzulli, J.R., Taylor, J.P., Krainc, D., Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J. Neurosci. 32 (2012), 4240–4246.
215. Vaarmann, A., Gandhi, S., Abramov, A.Y., Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase. J. Biol. Chem. 285 (2010), 25018–25023.
216. Vanha-Perttula, T., Hopsu, V.K., Sonninen, V., Glenner, G.G., Cathepsin C activity as related to some histochemical substrates. Histochemie 5 (1965), 170–181.
217. Vanier, M.T., Niemann-pick disease type C. Orphanet J. Rare Dis., 5, 2010, 16.
218. Vincent, A.J., Gasperini, R., Foa, L., Small, D.H., Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity. J. Alzheimers Dis. 22 (2010), 699–714.
219. Vitner, E.B., Platt, F.M., Futerman, A.H., Common and uncommon pathogenic cascades in lysosomal storage diseases. J. Biol. Chem. 285 (2010), 20423–20427.
220. Volterra, A., Liaudet, N., Savtchouk, I., Astrocyte Ca(2)(+) signalling: an unexpected complexity. Nat. Rev. Neurosci. 15 (2014), 327–335.
221. Walden, C.M., Sandhoff, R., Chuang, C.C., Yildiz, Y., Butters, T.D., Dwek, R.A., Platt, F.M., van der Spoel, A.C., Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis. J. Biol. Chem. 282 (2007), 32655–32664.
222. Walkley, S.U., James, L.F., Locoweed-induced neuronal storage disease characterized by meganeurite formation. Brain Res. 324 (1984), 145–150.
223. Walkley, S.U., Vanier, M.T., Secondary lipid accumulation in lysosomal disease. Biochim. Biophys. Acta 1793 (2009), 726–736.
224. Walkley, S.U., Siegel, D.A., Dobrenis, K., Zervas, M., GM2 ganglioside as a regulator of pyramidal neuron dendritogenesis. Ann. N. Y. Acad. Sci. 845 (1998), 188–199.
225. Walkley, S.U., Zervas, M., Wiseman, S., Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons. Cereb. Cortex 10 (2000), 1028–1037.
226. Walkley, S.U., Sikora, J., Micsenyi, M., Davidson, C., Dobrenis, K., Lysosomal compromise and brain dysfunction: examining the role of neuroaxonal dystrophy. Biochem. Soc. Trans. 38 (2010), 1436–1441.
227. Walkley, S.U., Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity. Neuroscience 68 (1995), 1027–1035.
228. Waller-Evans, H., Lloyd-Evans, E., Regulation of TRPML1 function. Biochem. Soc. Trans. 43 (2015), 442–446.
229. Wang, R.Y., Lelis, A., Mirocha, J., Wilcox, W.R., Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet. Med. 9 (2007), 34–45.
230. Wassif, C.A., Cross, J.L., Iben, J., Sanchez-Pulido, L., Cougnoux, A., Platt, F.M., Ory, D.S., Ponting, C.P., Bailey-Wilson, J.E., Biesecker, L.G., Porter, F.D., High incidence of unrecognized visceral/neurological late-onset Niemann-pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet. Med. 18 (2016), 41–48.
231. Wilkening, G., Linke, T., Sandhoff, K., Lysosomal degradation on vesicular membrane surfaces: enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J. Biol. Chem. 273 (1998), 30271–30278.
232. Wolfe, D.M., Lee, J.H., Kumar, A., Lee, S., Orenstein, S.J., Nixon, R.A., Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur. J. Neurosci. 37 (2013), 1949–1961.
233. Wong, K., Sidransky, E., Verma, A., Mixon, T., Sandberg, G.D., Wakefield, L.K., Morrison, A., Lwin, A., Colegial, C., Allman, J.M., Schiffmann, R., Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol. Genet. Metab. 82 (2004), 192–207.
234. Wong, C.O., Li, R., Montell, C., Venkatachalam, K., Drosophila TRPML is required for TORC1 activation. Curr. Biol. 22 (2012), 1616–1621.
235. Wright, L.M., Levy, E.S., Patel, N.P., Alhadeff, J.A., Purification and characterization of cathepsin D from normal human breast tissue. J. Protein Chem. 16 (1997), 171–181.
236. Yamazaki, T., Chang, T.Y., Haass, C., Ihara, Y., Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J. Biol. Chem. 276 (2001), 4454–4460.
237. Yanagisawa, K., Odaka, A., Suzuki, N., Ihara, Y., GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1 (1995), 1062–1066.
238. Yang, D.S., Stavrides, P., Saito, M., Kumar, A., Rodriguez-Navarro, J.A., Pawlik, M., Huo, C., Walkley, S.U., Saito, M., Cuervo, A.M., Nixon, R.A., Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits. Brain 137 (2014), 3300–3318.
239. Yao, Z.X., Papadopoulos, V., Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity. FASEB J. 16 (2002), 1677–1679.
240. Yao, J., Ho, D., Calingasan, N.Y., Pipalia, N.H., Lin, M.T., Beal, M.F., Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. J. Exp. Med. 209 (2012), 2501–2513.
241. Yu, W., Gong, J.S., Ko, M., Garver, W.S., Yanagisawa, K., Michikawa, M., Altered cholesterol metabolism in Niemann-pick type C1 mouse brains affects mitochondrial function. J. Biol. Chem. 280 (2005), 11731–11739.
242. Zhang, L., Sheng, R., Qin, Z., The lysosome and neurodegenerative diseases. Acta Biochim. Biophys. Sin. (Shanghai) 41 (2009), 437–445.
243. Zhang, X., Garbett, K., Veeraraghavalu, K., Wilburn, B., Gilmore, R., Mirnics, K., Sisodia, S.S., A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J. Neurosci. 32 (2012), 8633–8648.
244. Zhu, L., Zhong, M., Zhao, J., Rhee, H., Caesar, I., Knight, E.M., Volpicelli-Daley, L., Bustos, V., Netzer, W., Liu, L., Lucast, L., Ehrlich, M.E., Robakis, N.K., Gandy, S.E., Cai, D., Reduction of synaptojanin 1 accelerates Abeta clearance and attenuates cognitive deterioration in an Alzheimer mouse model. J. Biol. Chem. 288 (2013), 32050–32063.
245. Zou, J., Hu, B., Arpag, S., Yan, Q., Hamilton, A., Zeng, Y.S., Vanoye, C.G., Li, J., Reactivation of lysosomal Ca2+ efflux rescues abnormal lysosomal storage in FIG4-deficient cells. J. Neurosci. 35 (2015), 6801–6812.
246. van Veen, S., Sorensen, D.M., Holemans, T., Holen, H.W., Palmgren, M.G., Vangheluwe, P., Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders. Front. Mol. Neurosci., 7, 2014, 48.
247. von Trotha, K.T., Heun, R., Schmitz, S., Lutjohann, D., Maier, W., Kolsch, H., Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism. Neurosci. Lett. 402 (2006), 262–266.